A detailed history of Kmg Fiduciary Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kmg Fiduciary Partners, LLC holds 31,066 shares of BMY stock, worth $1.77 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
31,066
Previous 30,448 2.03%
Holding current value
$1.77 Million
Previous $1.26 Million 27.14%
% of portfolio
0.14%
Previous 0.12%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$39.66 - $51.75 $24,509 - $31,981
618 Added 2.03%
31,066 $1.61 Million
Q2 2024

Jul 17, 2024

BUY
$40.25 - $52.99 $118,496 - $156,002
2,944 Added 10.7%
30,448 $1.26 Million
Q1 2024

Apr 10, 2024

BUY
$47.98 - $54.4 $52,394 - $59,404
1,092 Added 4.13%
27,504 $1.49 Million
Q4 2023

Jan 10, 2024

SELL
$48.48 - $57.85 $231,104 - $275,770
-4,767 Reduced 15.29%
26,412 $1.36 Million
Q3 2023

Oct 25, 2023

SELL
$57.89 - $64.73 $98,355 - $109,976
-1,699 Reduced 5.17%
31,179 $1.81 Million
Q2 2023

Jul 14, 2023

BUY
$63.71 - $70.74 $4,650 - $5,164
73 Added 0.22%
32,878 $2.1 Million
Q1 2023

Apr 13, 2023

BUY
$65.71 - $74.53 $93,571 - $106,130
1,424 Added 4.54%
32,805 $2.27 Million
Q4 2022

Jan 12, 2023

BUY
$68.48 - $81.09 $252,211 - $298,654
3,683 Added 13.3%
31,381 $0
Q3 2022

Oct 27, 2022

SELL
$0.13 - $76.84 $604 - $357,075
-4,647 Reduced 14.37%
27,698 $1.97 Million
Q2 2022

Jul 13, 2022

BUY
$72.62 - $79.98 $30,573 - $33,671
421 Added 1.32%
32,345 $2.49 Million
Q1 2022

Apr 19, 2022

BUY
$61.48 - $73.72 $271,188 - $325,178
4,411 Added 16.03%
31,924 $2.33 Million
Q4 2021

Jan 12, 2022

SELL
$53.63 - $62.52 $102,272 - $119,225
-1,907 Reduced 6.48%
27,513 $1.72 Million
Q3 2021

Oct 12, 2021

SELL
$59.17 - $69.31 $63,193 - $74,023
-1,068 Reduced 3.5%
29,420 $1.74 Million
Q2 2021

Jul 20, 2021

BUY
$61.91 - $67.42 $61,167 - $66,610
988 Added 3.35%
30,488 $2.04 Million
Q1 2021

Apr 08, 2021

BUY
$59.34 - $66.74 $272,311 - $306,269
4,589 Added 18.42%
29,500 $1.86 Million
Q4 2020

Jan 13, 2021

BUY
$57.74 - $65.43 $208,903 - $236,725
3,618 Added 16.99%
24,911 $1.53 Million
Q3 2020

Oct 13, 2020

BUY
$57.43 - $63.64 $362,900 - $402,141
6,319 Added 42.2%
21,293 $1.28 Million
Q2 2020

Jul 22, 2020

BUY
$54.82 - $64.09 $411,478 - $481,059
7,506 Added 100.51%
14,974 $880,000
Q1 2020

Apr 29, 2020

BUY
$46.4 - $67.43 $52,710 - $76,600
1,136 Added 17.94%
7,468 $416,000
Q4 2019

Jan 29, 2020

BUY
$49.21 - $64.19 $64,563 - $84,217
1,312 Added 26.14%
6,332 $406,000
Q2 2019

Jul 26, 2019

SELL
$44.62 - $49.34 $6,336 - $7,006
-142 Reduced 2.75%
5,020 $228,000
Q4 2018

Apr 15, 2019

BUY
$48.76 - $63.23 $251,699 - $326,393
5,162 New
5,162 $268,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Kmg Fiduciary Partners, LLC Portfolio

Follow Kmg Fiduciary Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kmg Fiduciary Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kmg Fiduciary Partners, LLC with notifications on news.